Post COVID-19 Vaccination Support

Coverage Period

Start : 24 May 2021 

End:  31 December 2021

Reimbursement of medical bills incurred due to serious adverse effect(s) from immunisation (“AEFI”) within 14 days after receiving an approved COVID-19 Vaccine, capped at maximum limit of RM5,000 per life. 

• “COVID-19 Vaccine” shall refer any COVID-19 vaccines (including the first dose and subsequent doses) that is approved by the Ministry of Health (MOH) or relevant Malaysian authorities and must be carried out at a location designated by MOH in Malaysia.
  
  
•  “Serious AEFI” shall refer to any medical conditions that is life-threatening, which may result in persistent or significant disability/incapacity and requires in-patient hospitalisation, for medical intervention to prevent permanent impairment or damage.
  
  
• The amount to be reimbursed under this benefit shall be subject to the eligible expenses entitled as per Benefit Schedule of the respective medical policies.
  
  
• Other terms and conditions of the medical policy such as the standard Waiting Period shall apply.
  
  
• Manulife reserves the right to change the terms and conditions from time to time and/or terminate this complimentary benefit earlier, should the prevailing conditions and circumstances change.